Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sangamo Therapeutics
(NQ:
SGMO
)
0.5178
+0.0148 (+2.94%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Sangamo Therapeutics
< Previous
1
2
3
4
Next >
Soon After Novartis & Biogen Walked Away From Neurology Drug Partnerships, Sangamo Announces Major Restructuring
April 27, 2023
Sangamo Therapeutics Inc (NASDAQ: SGMO) announced cutting 27% of its workforce, prioritizing its pipeline, and changing its corporate structure to save about $31 million to fund operations for at least...
Via
Benzinga
Sangamo Therapeutics's Earnings Outlook
April 25, 2023
Via
Benzinga
This Biotech's Stock Has Been Under Pressure, Could Upcoming Clinical Trials Of Its Nanotechnology-Based COVID Drug Candidate Be The Start Of An Upward March?
April 19, 2023
A company that seems to have seen poor market sentiment lately is NanoViricides Inc. (NYSEAMERICAN: NNVC), a pharmaceutical company specializing in the development of nanomedicine drugs for treating...
Via
Benzinga
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
April 16, 2023
You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards.
Via
InvestorPlace
Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session
April 14, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 15, 2023
On Wednesday, 479 stocks made new 52-week lows.
Via
Benzinga
What 4 Analyst Ratings Have To Say About Sangamo Therapeutics
March 03, 2023
Via
Benzinga
Earnings Preview For Sangamo Therapeutics
February 21, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
April 10, 2023
Monday's session saw 114 companies set new 52-week lows.
Via
Benzinga
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
March 25, 2023
Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it.
Via
InvestorPlace
Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo
March 20, 2023
Two big-name partners have walked away from partnerships with Sangamo Therapeutics Inc (NASDAQ: SGMO) over a few days.
Via
Benzinga
UBS Group, Credit Suisse And Other Big Stocks Moving Lower In Monday's Pre-Market Session
March 20, 2023
U.S. stock futures traded mostly lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 17, 2023
Via
Benzinga
10 Companies That Had Tons of Money in SVB When It Collapsed
March 13, 2023
Silicon Valley Bank is gone but its clients are still here. Many prominent companies, and not just startups, had money in SVB.
Via
InvestorPlace
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 27, 2023
February 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 27, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 24, 2023
On Friday, 135 companies reached new 52-week lows.
Via
Benzinga
Sangamo Therapeutics Shares Updated Data From Fabry Gene Therapy Study, Says It Shows Evidence Of Clinical Benefit
February 23, 2023
Via
Benzinga
Why Bionano Genomics, Pacific Biosciences of California, and Sangamo Therapeutics Stocks Crumbled This Week
February 10, 2023
These cutting-edge biotech companies quickly fell out of favor with investors this week.
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
December 28, 2022
On Wednesday, 258 companies hit new 52-week lows.
Via
Benzinga
Earnings Scheduled For February 22, 2023
February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 22, 2022
Thursday's session saw 329 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 21, 2022
On Wednesday, 152 stocks made new 52-week lows.
Via
Benzinga
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 29, 2022
Protalix BioTherapeutics, Inc. (NYSE AMERICAN: PLX), an Israeli biopharmaceutical company, and Chiesi Global Rare Diseases, a business unit of the Chiesi Group,
Via
Benzinga
Sangamo Therapeutics's Earnings Outlook
November 02, 2022
Sangamo Therapeutics (NASDAQ:SGMO) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Earnings Scheduled For November 3, 2022
November 03, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Via
Benzinga
Sangamo Touts Additional Positive Data For Fabry Gene Therapy Candidate
October 12, 2022
Via
Benzinga
Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold
September 23, 2022
Via
Benzinga
Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions
September 20, 2022
As many investors are aware, options market data can provide some critical insight into future price movements of underlying common stock. It’s often possible to tell how the broader market perceives a...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.